 Endometrial cancer biochemical clinical correlates endometrial cancers endometrial adenocarcinoma cell lines amplified expression proto-oncogenes fos fms myc myb neu erb-B augmented production growth factors colony-stimulating factor epidermal growth factor growth factor-alpha growth factor beta epidermal growth factor receptor Oncogene expression presence estrogen progesterone receptors fraction cells phase useful biochemical prognostic indicators clinical outcome markers monoclonal antibodies available use clinical course disease treatment vivo vitro studies normal neoplastic tissues evidence paracrine influences epithelial cell proliferation Long-term administration tamoxifen adjuvant therapy breast cancer risk development endometrial cancer